Preview Mode Links will not work in preview mode

Sep 26, 2022

Featuring an interview with Dr Heather Wakelee, including the following topics:

  • Similarities and differences in the efficacy of neoadjuvant and adjuvant immunotherapies for localized non-small cell lung cancer (NSCLC) (0:00)
  • Available data on the treatment of patients whose disease relapses on or after adjuvant immunotherapy (6:15)
  • Activity of immunotherapy in patients whose tumors are EGFR mutated (10:29)
  • Case: A woman in her mid 70s with EGFR-mutated NSCLC in her right lung (14:49)
  • Case: A woman in her early 60s with a smoking history and a 4-cm right lower lobe lesion (24:17)
  • Case: A man in his mid 50s with a smoking history and a left upper lobe mass with high PD-L1 expression (28:04)
  • Optimal treatment of localized NSCLC in patients who have alterations in RET, BRAF and ALK (33:08)
  • Importance of primary care doctors screening their patients for lung cancer (37:03)

CME information and select publications